Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant DNA method for producing erythromycin analogs

Recombinant DNA method for producing erythromycin analogs

US Patent 5824513 · Granted Oct 20, 1998

Estimated economic value: $344,325,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Producing 3-hydroxycarboxylic acid and ketone using polyketide synthases2023
Hybrid polyketide synthases2022
Producing adipic acid and related compounds using hybrid polyketide synthases2020
Hybrid polyketide synthases2019
Lantipeptide2019
Producing 3-hydroxycarboxylic acid and ketone using polyketide synthases2019
Producing alpha-olefins using polyketide synthases2018
Hybrid polyketide synthases2016
Cyclic peptide from Nonomuraea sp., process for the production thereof, and phar2015
Producing dicarboxylic acids using polyketide synthases2015
Producing a trimethylpentanoic acid using hybrid polyketide synthases2014
Genes and proteins for the biosynthesis of the lantibiotic 1078912013